Channing Capital Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-545,401
Closed -$47.7M 122
2019
Q4
$47.7M Sell
545,401
-49,511
-8% -$4.33M 2.21% 5
2019
Q3
$50.5M Buy
594,912
+42,736
+8% +$3.81M 2.34% 4
2019
Q2
$58.1M Sell
552,176
-21,674
-4% -$2.18M 2.7% 2
2019
Q1
$60.6M Sell
573,850
-150,992
-21% -$15.2M 2.8% 5
2018
Q4
$60.7M Buy
724,842
+55,363
+8% +$5.01M 3.04% 2
2018
Q3
$68.2M Sell
669,479
-140,989
-17% -$13.6M 2.46% 12
2018
Q2
$65.5M Sell
810,468
-91,408
-10% -$7.26M 2.32% 13
2018
Q1
$66.5M Sell
901,876
-137,098
-13% -$10.3M 2.33% 11
2017
Q4
$73.2M Buy
1,038,974
+105,991
+11% +$7.65M 2.47% 8
2017
Q3
$58.3M Buy
932,983
+31,153
+3% +$1.85M 2.19% 15
2017
Q2
$51.8M Buy
901,830
+70,130
+8% +$4.13M 2.02% 16
2017
Q1
$50.6M Buy
831,700
+560,900
+207% +$31.7M 1.85% 25
2016
Q4
$14.9M Buy
+270,800
New +$13M 0.53% 56

Other funds holding NGVT

Channing Capital Management's NGVT Position: Q1 2020 in Review

Channing Capital Management sold out of Ingevity (NGVT) in Q1 2020, closing a stake of 545,401 shares — an estimated $47.7M sold.

Channing Capital Management first reported a position in NGVT in Q4 2016 and held it in 13 quarters. The position peaked at $73.2M in Q4 2017. 272 funds tracked by Wall St. Rank hold NGVT as of Q1 2020.

  • Channing Capital Management reported no remaining Ingevity position as of Q1 2020 after selling out during the quarter.
  • Channing Capital Management sold 545,401 Ingevity shares in Q1 2020, an estimated $47.7M.
  • Channing Capital Management first reported a position in Ingevity in Q4 2016 and held it in 13 quarters.
  • Channing Capital Management's Ingevity position peaked at $73.2M in Q4 2017.
  • 272 funds tracked by Wall St. Rank held Ingevity as of Q1 2020.

Based on Channing Capital Management's 13F filing for Q1 2020, filed 13 May 2020.